Suppression of Homologous Recombination by insulin-like growth factor-1 inhibition sensitizes cancer cells to PARP inhibitors

BACKGROUND: Impairment of homologous recombination (HR) is found in close to 50 % of ovarian and breast cancer. Tumors with BRCA1 mutations show increased expression of the Insulin-like growth factor type 1 receptor (IGF-1R). We previously have shown that inhibition of IGF-1R results in growth inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Amin, Oreekha, Beauchamp, Marie-Claude, Nader, Paul Abou, Laskov, Ido, Iqbal, Sanaa, Philip, Charles-André, Yasmeen, Amber, Gotlieb, Walter H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625613/
https://www.ncbi.nlm.nih.gov/pubmed/26510816
http://dx.doi.org/10.1186/s12885-015-1803-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625613/
https://www.ncbi.nlm.nih.gov/pubmed/26510816
http://dx.doi.org/10.1186/s12885-015-1803-y

Ejemplares similares